跳至主要内容
临床试验/ACTRN12605000588695
ACTRN12605000588695已完成3 期

eoadjuvant chemotherapy with docetaxel and anthracycline based chemotherapy in patients with advanced breast cancer: Evaluation of biological, clinical and imaging markers of tumour response

Monash Health0 个研究点目标入组 180 人开始时间: 2005年10月4日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
Monash Health
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
Female

入选标准

  • locally advanced breast cancer

排除标准

  • metastatic disease (Stage 4)

研究者

发起方
Monash Health

相似试验

已完成
不适用
Adjuvant chemotherapy combined with docetaxel and cyclophosphamide for Japanese breast cancer patients without lymph node metastasis or with three and under lymph node metastasis.Breast cancer
JPRN-UMIN000002310Gunma Breast Cancer Research Group 2 surgery90
进行中(未招募)
1 期
eoadjuvant, sequential chemotherapy with docetaxel followed by Fluorouracil, Epirubicin, and Cyclophosphamid every 3 weeks - genome wide expression analysis for identification of a predictive gene signature in patients with primary breast cancer - EXPRESSIOEligible will be only females between 18 - 70 years of age, suffering from histologically confirmed primary breast cancer, nodal status positive or negative, phase cT2, cT3, or cT4 including inflammatory disease. Metastatic disease is excluded. All patients will be treated with 3 cycles Docetaxel and 3 cycles FEC.MedDRA version: 14.1Level: PTClassification code 10006201Term: Breast cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10021974Term: Inflammatory breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10006202Term: Breast cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10006200Term: Breast cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2008-006381-29-DEniversitätsmedizin Mainz200
已完成
不适用
eo adjuvant chemotherapy by Docetaxel + S-1 for resentable gasric cabcergastric cancer
JPRN-UMIN000015632Department of Frontier Surgery, Graduate school of Medicine, Chiba University20
进行中(未招募)
不适用
eoadjuvant chemotherapywith weekly docetaxel followed from concomitant docetaxel-RT in patients with high risk locally advancedprostate cancer - docrtpchigh risk locally advancedprostate cancerMedDRA version: 9.1Level: LLTClassification code 10060862Term: Prostate cancer
EUCTR2008-003525-16-ITISTITUTI FISIOTERAPICI OSPITALIERI
进行中(未招募)
2 期
Induction chemotherapy for HPV positive oropharyngeal cancers (HIPPOCRATES)Human papillomavirus-associated oropharyngeal cancersHuman papillomavirus, oropharyngeal cancers
JPRN-jRCT1041220029Yokota Tomoya30